111 related articles for article (PubMed ID: 1721365)
1. FK 506 conversion of renal allografts failing cyclosporine immunosuppression.
Jordan ML; Shapiro R; Jensen CW; Scantlebury V; Fung J; Tzakis A; McCauley J; Jain A; Demetrius J; Randhawa P
Transplant Proc; 1991 Dec; 23(6):3078-81. PubMed ID: 1721365
[No Abstract] [Full Text] [Related]
2. FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.
Jordan ML; Shapiro R; Vivas CA; Scantlebury VP; Darras FS; Carrieri G; McCauley J; Demetris AJ; Randhawa P; Jensen C
Transplant Proc; 1993 Feb; 25(1 Pt 1):638-40. PubMed ID: 7679827
[No Abstract] [Full Text] [Related]
3. New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.
Scantlebury V; Shapiro R; Fung J; Tzakis A; McCauley J; Jordan M; Jensen C; Hakala T; Simmons R; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3169-70. PubMed ID: 1721395
[No Abstract] [Full Text] [Related]
4. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
[No Abstract] [Full Text] [Related]
5. Tacrolimus (FK 506) in kidney transplantation.
Vanrenterghem Y
Transplant Proc; 1998 Aug; 30(5):2171-3. PubMed ID: 9723431
[No Abstract] [Full Text] [Related]
6. Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients.
Takahara S; Kokado Y; Kameoka H; Takano Y; Moutabarrik A; Jiang H; Ishibashi M; Okuyama A; Nishi Y; Chiba N
Transplant Proc; 1994 Oct; 26(5):2802-6. PubMed ID: 7524219
[No Abstract] [Full Text] [Related]
7. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression.
Sugito K; Morozumi K; Oikawa T
Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683
[No Abstract] [Full Text] [Related]
8. Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.
McCauley J; Shapiro R; Bronster O; Jordan M; Ellis D; Gilboa N; Scantlebury V; Jensen C; Jain A; Starzl T
Transplant Proc; 1991 Dec; 23(6):3068-70. PubMed ID: 1721362
[No Abstract] [Full Text] [Related]
9. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
[TBL] [Abstract][Full Text] [Related]
10. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
11. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
12. FK 506 in the management of nephrotic syndrome after renal transplantation.
McCauley J; Shapiro R; Jordan M; Scantlebury V; Vivas C; Jensen C; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 2):1351-4. PubMed ID: 7680154
[No Abstract] [Full Text] [Related]
13. FK 506 in clinical kidney transplantation.
Shapiro R; Jordan M; Scantlebury V; Fung J; Jensen C; Tzakis A; McCauley J; Carroll P; Ricordi C; Demetris AJ
Transplant Proc; 1991 Dec; 23(6):3065-7. PubMed ID: 1721361
[No Abstract] [Full Text] [Related]
14. Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression.
Hu RH; Lee CY; Tsai MK; Lee PH
Transplant Proc; 2004 Sep; 36(7):2092-5. PubMed ID: 15518757
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
Fung J; Abu-Elmagd K; Jain A; Gordon R; Tzakis A; Todo S; Takaya S; Alessiani M; Demetris A; Bronster O
Transplant Proc; 1991 Dec; 23(6):2977-83. PubMed ID: 1721333
[No Abstract] [Full Text] [Related]
16. Histopathologic findings in routine biopsies of renal transplant allografts.
Toki K; Kyo M; Takahara S; Hatori M; Morozumi K; Ichimaru N; Wang JD; Ding XQ; Miyamoto M; Oka K; Kyakuno M; Kojima Y; Kokado Y; Okuyama A
Transplant Proc; 1999 Sep; 31(6):2655-8. PubMed ID: 10500759
[No Abstract] [Full Text] [Related]
17. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
18. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
[No Abstract] [Full Text] [Related]
20. Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection.
Morales E; Andrés A; Herrero JC; Dominguez-Gil B; Carreño A; Morales JM; Hernández E; Ortuño T; Praga M
Transplant Proc; 1999 Sep; 31(6):2248-9. PubMed ID: 10500562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
